Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Potential HCV Blockbuster, Strong Fundraising Place Vertex In Enviable Position

Dec 29 2008

Related Content

Market Likes Telaprevir For Twice-daily Dosing

Sep 25 2008

Vertex Sells Lexiva, Agenerase Royalties For $160M

Jun 03 2008

More Positive Phase IIa Data May Have Vertex CF Drug On Registration Path

Oct 20 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window